PeptideDB

Clenoliximab

CAS No.: 182912-58-9

Clenoliximab (IDEC-151), a macaque-human chimeric monoclonal antibody (immunoglobulin G4), targets the CD4 molecule on T
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Clenoliximab (IDEC-151), a macaque-human chimeric monoclonal antibody (immunoglobulin G4), targets the CD4 molecule on T lymphocytes' surface and is utilized in rheumatoid arthritis research [1].
Synonyms IDEC-151
molecular weight N/A
CAS 182912-58-9
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 years